Chiome Bioscience Inc. announced that they have resolved to enter into an entrustment agreement with Takeda Pharmaceutical Company Limited for antibody generation using the ADLib system, antibody generation technology. They have had entered into a separate outsourcing agreement with Takeda to conduct antibody generation, etc. using the ADLib® System.

By entering into the Entrusment Agreement, they will be able to provide research support services rapidly to Takeda, such as antibody production.